These results, along with a prior report exhibiting that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 assist the principle of focusing on ACKR3 as a novel way to modulate the opioid process, which could open up new therapeutic avenues for opioid-similar Diseases. (2) The doctor has https://jessicay255fvi6.idblogz.com/profile